Penny Hoglund

Penny Hoglund is currently the Director of Provider Referrals at Stella Center. Prior to that, they were an Account Executive with Myriad Genetics from July 2018 to October 2019. There, they developed and implemented a territory-level business plan to drive business and exceed sales goals in a defined territory by educating and influencing physicians and staff to integrate a process to assist in the identification and testing of patients at risk for hereditary cancer and other genetic diseases.

From September 2017 to September 2019, Penny Hoglund served on the Advisory Board for Miller Vein. In this role, they focused on market expansion through developing and executing sales strategies to increase patient acquisition through various channels. Penny also developed quality referral sources concentrating on building strong relationships through education around the unique model of care, services, and treatment options offered at CTCA.

Prior to their roles at Myriad Genetics and Miller Vein, Penny Hoglund was a Territory Manager IV, Sales & Business Development at Cancer Treatment Centers of America from January 2015 to March 2018. There, they identified business development opportunities that enabled enterprise growth through mergers and acquisitions, joint ventures, and strategic alliances.

Penny Hoglund has a BFA from Delta State University in Arts and Business. Penny also has certification from Myriad Genetics in The Challenger Sale, IntegraMed Fertility in Spin Selling, Miller Heiman Group in Strategic Selling, and Prairie Yoga Studio in Certified Yoga Teacher.

Some of their coworkers include Ali Holmes - Controller, Rachel Mahoney - Head of Business Development, and Val Groth - Head of Partnerships. Penny Hoglund reports to Michael Gershenzon, Chief Strategy Officer.